In IPF, where persistent fibroblast activation underlies progressive fibrotic disease, HDAC-mediated gene repression of antifibrotic molecules and proapoptotic factors appears to be a critical event [162,163,164,246]. The gene discussed is HDAC9; the disease is idiopathic pulmonary fibrosis.